US Exchange: 3 Stocks That May Be Trading Below Fair Value

As the U.S. stock market pulls back from recent record highs, investors are closely monitoring economic indicators and Federal Reserve policies that could influence future trends. In this environment, identifying stocks that may be trading below their fair value can present opportunities for those looking to capitalize on potential market inefficiencies.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
Clear Secure (NYSE:YOU)	$26.98	$53.27	49.4%
UMB Financial (NasdaqGS:UMBF)	$122.36	$244.39	49.9%
Business First Bancshares (NasdaqGS:BFST)	$28.29	$55.10	48.7%
West Bancorporation (NasdaqGS:WTBA)	$23.59	$46.42	49.2%
Equity Bancshares (NYSE:EQBK)	$46.75	$92.77	49.6%
U.S. Physical Therapy (NYSE:USPH)	$94.06	$187.03	49.7%
Constellium (NYSE:CSTM)	$11.31	$22.03	48.7%
Freshpet (NasdaqGM:FRPT)	$145.69	$283.12	48.5%
Equifax (NYSE:EFX)	$265.29	$529.48	49.9%
Marcus & Millichap (NYSE:MMI)	$40.82	$81.04	49.6%

Click here to see the full list of 194 stocks from our Undervalued US Stocks Based On Cash Flows screener.

We'll examine a selection from our screener results.

Veracyte (NasdaqGM:VCYT)

Overview: Veracyte, Inc. is a diagnostics company that operates in the United States and internationally, with a market cap of $3.37 billion.

Operations: The company generates revenue from its Diagnostic Products segment, amounting to $425.33 million.

Estimated Discount To Fair Value: 16.6%

Veracyte's recent financial performance indicates a positive turnaround with a net income of US$15.16 million in Q3 2024, compared to a loss last year. The company raised its revenue guidance for 2024, reflecting strong growth prospects. Although trading below fair value by approximately 16.6%, Veracyte's shares have experienced dilution over the past year. With expected annual profit growth above market averages and improving cash flows, Veracyte presents potential undervaluation based on these metrics.

• Our growth report here indicates Veracyte may be poised for an improving outlook.
• Take a closer look at Veracyte's balance sheet health here in our report.

CoStar Group (NasdaqGS:CSGP)

Overview: CoStar Group, Inc. offers information, analytics, and online marketplace services to professionals in the commercial real estate, hospitality, and residential sectors across various regions including the United States, with a market cap of approximately $31.80 billion.

Operations: The company's revenue segment includes Internet Information Providers, generating $2.67 billion.

Estimated Discount To Fair Value: 23.3%

CoStar Group's stock, trading at US$78.25, is undervalued by over 20% based on discounted cash flow analysis with a fair value estimate of US$101.99. Despite a decline in profit margins from 16.9% to 6.6%, earnings are expected to grow significantly at over 42% annually, outpacing the market average. Recent strategic moves include acquiring prime office space in Arlington for headquarters relocation, enhancing operational efficiency amidst ongoing revenue growth and expansion efforts.

• Upon reviewing our latest growth report, CoStar Group's projected financial performance appears quite optimistic.
• Click here to discover the nuances of CoStar Group with our detailed financial health report.

Paycor HCM (NasdaqGS:PYCR)

Overview: Paycor HCM, Inc. provides human capital management solutions for small and medium-sized businesses in the United States and has a market cap of approximately $3.52 billion.

Operations: The company's revenue is primarily derived from its Internet Software & Services segment, which generated $678.84 million.

Estimated Discount To Fair Value: 47.4%

Paycor HCM's stock, priced at US$20.25, is undervalued by over 47% with a fair value estimate of US$38.47 based on discounted cash flow analysis. Revenue growth is projected at 10.4% annually, surpassing the overall market rate and indicating strong future prospects as earnings are expected to grow significantly by 56.58% per year. Recent innovations like Paycor Assistant and an Integration Platform enhance operational capabilities, positioning the company for strategic growth in HR technology solutions.

• Our comprehensive growth report raises the possibility that Paycor HCM is poised for substantial financial growth.
• Navigate through the intricacies of Paycor HCM with our comprehensive financial health report here.

Seize The Opportunity

• Discover the full array of 194 Undervalued US Stocks Based On Cash Flows right here.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com